Identification of Three Distinct Subgroups in Antiphospholipid Syndrome: Implication for Sex Differences and Prognostic Outcomes from a Multicenter Study.
Chen Chen, Ao Zhang, Jianhui Cheng...
https://pubmed.ncbi.nlm.nih.gov/39965097/Actively Recruiting
Led by New Valley University · Updated on 2026-10-28
200
Participants Needed
1
Research Sites
13 weeks
Total Duration
Researchers are investigating thrombocytopenia patterns in people with antiphospholipid syndrome APS, a condition where low platelet counts are linked to worse health outcomes including higher risks of blood clots, pregnancy problems, and neurological issues. This study focuses on how changes in platelet levels over time relate to disease severity and survival, an area not fully studied before. The research is led by New Valley University and aims to better understand these platelet trends as a dynamic biomarker for APS severity. Participants with confirmed APS and persistent antiphospholipid antibodies will have their historical platelet counts collected and analyzed to classify them into groups based on their platelet count patterns over at least a year. These groups include stable normal platelet counts, intermittent or fluctuating thrombocytopenia, and persistent thrombocytopenia. This approach uses advanced modeling to explore how these platelet trajectories relate to clinical outcomes. During the study, researchers will review platelet data from routine visits and hospital stays. They will measure outcomes including death from any cause over a follow-up of up to five years, and the number of recurrent blood clots. This study will provide insights into how platelet trends affect long-term health in APS. Participants will be monitored through existing medical records without additional interventions, and the study is expected to complete by the end of 2027.
CONDITIONS
Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort Study
A
Asmaa N Hussein, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
New Valley University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Chen Chen, Ao Zhang, Jianhui Cheng...
https://pubmed.ncbi.nlm.nih.gov/39965097/Jiayang Jin, Mengyao Zhang, Xuanlin Cai...
https://pubmed.ncbi.nlm.nih.gov/40490817/Jiayang Jin, Xue Xu, Lei Hou...
https://pubmed.ncbi.nlm.nih.gov/36059524/Sherif Gamal, Samar Mohamed, Abdelkawy Moghazy
https://pubmed.ncbi.nlm.nih.gov/36017208/New Valley University
Lead Sponsor